Variant report
Variant | nsv818684 |
---|---|
Chromosome Location | chr9:9968038-9971050 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546654383 | chr9:9969609-9969610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183018405 | chr9:9969628-9969629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532206710 | chr9:9969639-9969640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114464789 | chr9:9969671-9969672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188649585 | chr9:9969698-9969699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77935221 | chr9:9969715-9969716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548056209 | chr9:9969737-9969738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115781727 | chr9:9969740-9969741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533848859 | chr9:9969748-9969749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192984013 | chr9:9969750-9969751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs59147123 | chr9:9969799-9969800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539880116 | chr9:9969851-9969852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183971201 | chr9:9969873-9969874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568224372 | chr9:9969882-9969883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7032996 | chr9:9969896-9969897 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs7033099 | chr9:9969939-9969940 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs542470804 | chr9:9969942-9969943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7860594 | chr9:9969965-9969966 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs187636703 | chr9:9969971-9969972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541770248 | chr9:9969993-9969994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560145331 | chr9:9969999-9970000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540044192 | chr9:9970000-9970001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192560706 | chr9:9970006-9970007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537092719 | chr9:9970010-9970011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183481555 | chr9:9970028-9970029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12338569 | chr9:9970033-9970034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370222300 | chr9:9970041-9970042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538419710 | chr9:9970052-9970053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112858695 | chr9:9970067-9970068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531514637 | chr9:9970073-9970074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547944921 | chr9:9970078-9970079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567933586 | chr9:9970163-9970164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142104128 | chr9:9970182-9970183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547297393 | chr9:9970183-9970184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7860148 | chr9:9970203-9970204 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs539494979 | chr9:9970243-9970244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556599124 | chr9:9970264-9970265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150737932 | chr9:9970278-9970279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535970556 | chr9:9970287-9970288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200159478 | chr9:9970291-9970292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572682843 | chr9:9970299-9970300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370655498 | chr9:9970306-9970307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541707007 | chr9:9970311-9970312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7857112 | chr9:9970319-9970320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs576772772 | chr9:9970325-9970326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7870418 | chr9:9970351-9970352 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs188160054 | chr9:9970374-9970375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531276072 | chr9:9970387-9970388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547883206 | chr9:9970398-9970399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561504138 | chr9:9970399-9970400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Schizophrenia | 23813976 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9969600-9970000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr9:9970000-9972800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr9:9970600-9971000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |